The laboratory manual of in-vitro susceptibility testing of the new glycylcycline of tigecycline

ou ,Yuxing Ni,Minjun Chen,Bijie Hu,Minggui Wang,Baiyi Chen,hujihong,Yunjian Hu

The laboratory manual of in-vitro susceptibility testing of the new glycylcycline of tigecycline

2009

ou
Yuxing Ni
Minjun Chen
Bijie Hu
Minggui Wang
Baiyi Chen
hujihong
Yunjian Hu

[编者按]替加环素(tigecyclin)是一种甘氨酰环素(glycylcycline)类抗生素,是半合成四环素米诺环素的衍生物.替加环素在细菌核糖体水平上抑制蛋白质合成,是针对MRSA及泛耐药鲍曼不动杆菌等耐药细菌有效的广谱抗菌药物.替加环素于2005年在美国上市,目前全球共有50多个国家和地区批准和上市了替加环素,预定2009年底将在中国上市.

Keywords:

susceptibility testing
Pharmacology
Glycylcycline
Tigecycline
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations